$VCYT
VERACYTE, INC. Stock $vcyt

$vcyt Overview Financials Valuation SEC Filings Company Website

2013 Q4 Form 10-Q Financial Statement

#000110465913086891 Filed on November 25, 2013

Income Statement

Concept	2013 Q4	2013 Q3	2012 Q3
Revenue	$6.838M	$5.594M	$3.224M
YoY Change	53.42%	73.51%
Cost Of Revenue	$3.470M	$3.132M	$1.984M
YoY Change	33.46%	57.86%
Gross Profit	$3.370M	$2.462M	$1.240M
YoY Change	81.18%	98.55%
Gross Profit Margin	49.28%	44.01%	38.46%
Selling, General & Admin	$7.260M	$6.535M	$4.450M
YoY Change	38.29%	46.85%
% of Gross Profit	215.43%	265.43%	358.87%
Research & Development	$1.870M	$2.028M	$1.729M
YoY Change	8.72%	17.29%
% of Gross Profit	55.49%	82.37%	139.44%
Depreciation & Amortization	$280.0K	$290.0K	$180.0K
YoY Change	55.56%	61.11%
% of Gross Profit	8.31%	11.78%	14.52%
Operating Expenses	$9.130M	$11.70M	$8.163M
YoY Change	30.99%	43.27%
Operating Profit	-$5.760M	-$6.101M	-$4.939M
YoY Change	12.72%	23.53%
Interest Expense	-$100.0K	$126.0K	$0.00
YoY Change
% of Operating Profit
Other Income/Expense, Net	-$30.00K	-$76.00K	$1.000K
YoY Change	-110.71%	-7700.0%
Pretax Income	-$5.890M	-$6.300M	-$4.940M
YoY Change	21.69%	27.53%
Income Tax	$0.00	$0.00	$0.00
% Of Pretax Income
Net Earnings	-$5.892M	-$6.303M	-$4.938M
YoY Change	21.81%	27.64%
Net Earnings / Revenue	-86.17%	-112.67%	-153.16%
Basic Earnings Per Share
Diluted Earnings Per Share	-$281.4K	-$301.0K	-$238.8K
COMMON SHARES
Basic Shares Outstanding	21.04M shares
Diluted Shares Outstanding

Balance Sheet

Concept	2013 Q4	2013 Q3	2012 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$71.20M	$15.40M
YoY Change
Cash & Equivalents	$71.22M	$15.43M	$3.441M
Short-Term Investments
Other Short-Term Assets	$1.500M	$2.900M
YoY Change
Inventory	$2.567M	$1.392M
Prepaid Expenses
Receivables	$1.143M	$714.0K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$76.41M	$20.47M
YoY Change	366.44%
LONG-TERM ASSETS
Property, Plant & Equipment	$2.952M	$2.826M
YoY Change	20.69%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$153.0K	$157.0K
YoY Change	25.41%
Total Long-Term Assets	$3.223M	$3.101M
YoY Change	19.99%
TOTAL ASSETS
Total Short-Term Assets	$76.41M	$20.47M
Total Long-Term Assets	$3.223M	$3.101M
Total Assets	$79.63M	$23.57M
YoY Change	317.63%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$5.294M	$5.604M
YoY Change	180.4%
Accrued Expenses	$7.594M	$4.416M
YoY Change	88.91%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$15.39M	$12.52M
YoY Change	71.15%
LONG-TERM LIABILITIES
Long-Term Debt	$4.899M	$4.863M
YoY Change
Other Long-Term Liabilities	$2.900M	$3.700M
YoY Change
Total Long-Term Liabilities	$4.899M	$4.863M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities	$15.39M	$12.52M
Total Long-Term Liabilities	$4.899M	$4.863M
Total Liabilities	$23.19M	$21.12M
YoY Change	63.68%
SHAREHOLDERS EQUITY
Retained Earnings	-$85.65M	-$79.76M
YoY Change	42.58%
Common Stock	$142.1M	$3.182M
YoY Change	8791.86%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$56.44M	-$76.58M
YoY Change
Total Liabilities & Shareholders Equity	$79.63M	$23.57M
YoY Change	317.63%

Cashflow Statement

Concept	2013 Q4	2013 Q3	2012 Q3
OPERATING ACTIVITIES
Net Income	-$5.892M	-$6.303M	-$4.938M
YoY Change	21.81%	27.64%
Depreciation, Depletion And Amortization	$280.0K	$290.0K	$180.0K
YoY Change	55.56%	61.11%
Cash From Operating Activities	-$3.300M	-$5.240M	-$5.270M
YoY Change	-15.17%	-0.57%
INVESTING ACTIVITIES
Capital Expenditures	-$270.0K	-$120.0K	-$270.0K
YoY Change	-50.91%	-55.56%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00
YoY Change
Cash From Investing Activities	-$270.0K	-$120.0K	-$270.0K
YoY Change	-50.91%	-55.56%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	59.36M	100.0K	0.000
YoY Change	295.73%
NET CHANGE
Cash From Operating Activities	-3.300M	-5.240M	-5.270M
Cash From Investing Activities	-270.0K	-120.0K	-270.0K
Cash From Financing Activities	59.36M	100.0K	0.000
Net Change In Cash	55.79M	-5.260M	-5.540M
YoY Change	428.31%	-5.05%
FREE CASH FLOW
Cash From Operating Activities	-$3.300M	-$5.240M	-$5.270M
Capital Expenditures	-$270.0K	-$120.0K	-$270.0K
Free Cash Flow	-$3.030M	-$5.120M	-$5.000M
YoY Change	-9.28%	2.4%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.46
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.69
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2227669000	shares
	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	324892000	shares
CY2013Q3	vcyt	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingNumber	1217163000	shares
CY2013Q3	vcyt	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingNumber	2234726000	shares
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	717000	USD
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.06
	dei	Entity Registrant Name EntityRegistrantName	VERACYTE, INC.
	dei	Entity Central Index Key EntityCentralIndexKey	0001384101
	dei	Document Type DocumentType	10-Q
	dei	Document Period End Date DocumentPeriodEndDate	2013-09-30
	dei	Amendment Flag AmendmentFlag	false
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	No
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2013Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	21035046	shares
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2013
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q3
	us-gaap	Use Of Estimates UseOfEstimates	<div style="font-size:10.0pt;font-family:Times New Roman;"> <p style="MARGIN: 0in 0in 0pt;"><b><i><font style="FONT-STYLE: italic; FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt; FONT-WEIGHT: bold;" size="2">Use of Estimates</font></i></b></p> <p style="MARGIN: 0in 0in 0pt;"> </p> <p style="TEXT-INDENT: 0.5in; MARGIN: 0in 0in 0pt;"><font style="FONT-FAMILY: Times New Roman; FONT-SIZE: 10pt;" size="2">The preparation of unaudited interim condensed financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities as of the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Significant items subject to such estimates include: revenue recognition; allowance for doubtful accounts; the useful lives of property and equipment; the recoverability of long-lived assets; the determination of fair value of the Company’s common stock, stock options, and preferred stock liability; income tax uncertainties, including a valuation allowance for deferred tax assets; and contingencies. The Company bases these estimates on historical and anticipated results, trends, and various other assumptions that the Company believes are reasonable under the circumstances, including assumptions as to future events. These estimates form the basis for making judgments about the carrying values of assets and liabilities and recorded revenue and expenses that are not readily apparent from other sources. Actual results could differ from those estimates and assumptions.</font></p> </div>
CY2013Q3	vcyt	Number Of Major Financial Institutions With Which Cash And Cash Equivalents Deposited NumberOfMajorFinancialInstitutionsWithWhichCashAndCashEquivalentsDeposited	2	item
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	168000	USD
CY2013Q3	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	118000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents At Carrying Value RestrictedCashAndCashEquivalentsAtCarryingValue	50000	USD
CY2013Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	5604000	USD
CY2012Q4	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	118000	USD
CY2013Q3	us-gaap	Restricted Cash And Cash Equivalents Noncurrent RestrictedCashAndCashEquivalentsNoncurrent	118000	USD
CY2013Q3	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	364000	USD
CY2012Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	222000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	184000	USD
	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	144000	USD
	us-gaap	Allowance For Doubtful Accounts Receivable Write Offs AllowanceForDoubtfulAccountsReceivableWriteOffs	34000	USD
CY2012Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	58000	USD
CY2013Q3	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	66000	USD
CY2012Q4	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	671000	USD
CY2013Q3	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	639000	USD
	vcyt	Revenue Recognition Number Of Criteria RevenueRecognitionNumberOfCriteria	2	item
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	183852000	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	2.81
CY2012Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1360000	USD
CY2013Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	1248000	USD
CY2012Q4	vcyt	Accrued Consulting Fees Current AccruedConsultingFeesCurrent	28000	USD
CY2013Q3	vcyt	Accrued Consulting Fees Current AccruedConsultingFeesCurrent	42000	USD
CY2012Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	84000	USD
CY2013Q3	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	294000	USD
CY2012Q4	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	2175000	USD
CY2013Q3	us-gaap	Accrued Marketing Costs Current AccruedMarketingCostsCurrent	2322000	USD
CY2012Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	373000	USD
CY2013Q3	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	510000	USD
CY2012Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4020000	USD
CY2013Q3	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4416000	USD
CY2012Q4	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	583000	USD
CY2013Q3	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliations Recurring Basis Liability Value FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue	252000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityGainLossIncludedInEarnings	-2070000	USD
	us-gaap	Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Settlements FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements	2653000	USD
	us-gaap	Proceeds From Issuance Of Long Term Debt ProceedsFromIssuanceOfLongTermDebt	4877000	USD
CY2011Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	7566000	USD
CY2013Q3	us-gaap	Share Price SharePrice	12.12
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	347386000	shares
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	144584000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Additional Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized	250000000	shares
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	636654000	shares
CY2013Q3	us-gaap	Temporary Equity Redemption Value TemporaryEquityRedemptionValue	79022000	USD
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.70
CY2012Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	5114000	USD
CY2013Q3	us-gaap	Liabilities Liabilities	21124000	USD
CY2012Q4	us-gaap	Liabilities Liabilities	14166000	USD
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2355579000	shares
CY2013Q3	vcyt	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingWeightedAverageExercisePrice	2.02
CY2013Q3	vcyt	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingWeightedAverageExercisePrice	2.77
CY2012Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4311000	USD
CY2013Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	21928000	USD
CY2013Q3	vcyt	Share Based Compensation Arrangement By Share Based Payment Award Options Vested Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedOutstandingAggregateIntrinsicValue	12290000	USD
CY2013Q3	vcyt	Share Based Compensation Arrangement By Share Based Payment Award Options Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpectedToVestOutstandingAggregateIntrinsicValue	20904000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	1.88
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.73
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	2.24
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	1.38
	vcyt	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue	0.92
	vcyt	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageGrantDateFairValue	0.98
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	112000	USD
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	3463000	USD
CY2013Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	15426000	USD
CY2012Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14002000	USD
CY2013Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	714000	USD
CY2012Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	569000	USD
CY2013Q3	us-gaap	Inventory Net InventoryNet	1392000	USD
CY2012Q4	us-gaap	Inventory Net InventoryNet	1050000	USD
CY2013Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	2938000	USD
CY2012Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	710000	USD
CY2013Q3	us-gaap	Assets Current AssetsCurrent	20470000	USD
CY2012Q4	us-gaap	Assets Current AssetsCurrent	16381000	USD
CY2013Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2826000	USD
CY2012Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2446000	USD
CY2013Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	157000	USD
CY2012Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	122000	USD
CY2013Q3	us-gaap	Assets Assets	23571000	USD
CY2012Q4	us-gaap	Assets Assets	19067000	USD
CY2012Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1888000	USD
CY2013Q3	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2500000	USD
CY2012Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2500000	USD
CY2012Q4	vcyt	Redeemable Convertible Preferred Stock Liabilities Current RedeemableConvertiblePreferredStockLiabilitiesCurrent	583000	USD
CY2013Q3	us-gaap	Liabilities Current LiabilitiesCurrent	12520000	USD
CY2012Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8991000	USD
CY2013Q3	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	4863000	USD
CY2013Q3	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	250000	USD
CY2012Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	61000	USD
CY2013Q3	vcyt	Redeemable Convertible Preferred Stock Warrants RedeemableConvertiblePreferredStockWarrants	252000	USD
CY2013Q3	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	3239000	USD
CY2012Q4	us-gaap	Temporary Equity Redemption Value TemporaryEquityRedemptionValue	63372000	USD
CY2013Q3	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2012Q4	us-gaap	Common Stock Value CommonStockValue	1000	USD
CY2013Q3	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	3181000	USD
CY2012Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	1597000	USD
CY2013Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-79757000	USD
CY2012Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-60069000	USD
CY2013Q3	us-gaap	Stockholders Equity StockholdersEquity	-76575000	USD
CY2012Q4	us-gaap	Stockholders Equity StockholdersEquity	-58471000	USD
CY2013Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23571000	USD
CY2012Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	19067000	USD
CY2012Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		USD
CY2013Q3	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Temporary Equity Par Or Stated Value Per Share TemporaryEquityParOrStatedValuePerShare	0.001
CY2013Q3	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	60187700	shares
CY2012Q4	us-gaap	Temporary Equity Shares Authorized TemporaryEquitySharesAuthorized	59147999	shares
CY2013Q3	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	59989268	shares
CY2013Q3	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	59989268	shares
CY2012Q4	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	53084507	shares
CY2012Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	53084507	shares
CY2013Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2012Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2013Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	77000000	shares
CY2012Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	77000000	shares
CY2013Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	992578	shares
CY2013Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	992578	shares
CY2012Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	667684	shares
CY2012Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	667684	shares
CY2013Q3	us-gaap	Sales Revenue Net SalesRevenueNet	5594000	USD
CY2012Q3	us-gaap	Sales Revenue Net SalesRevenueNet	3224000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	15046000	USD
	us-gaap	Sales Revenue Net SalesRevenueNet	7171000	USD
CY2013Q3	us-gaap	Cost Of Revenue CostOfRevenue	3132000	USD
CY2012Q3	us-gaap	Cost Of Revenue CostOfRevenue	1984000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	9136000	USD
	us-gaap	Cost Of Revenue CostOfRevenue	4984000	USD
CY2013Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	2028000	USD
CY2012Q3	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1729000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	5940000	USD
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	4887000	USD
CY2013Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	3291000	USD
CY2012Q3	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2347000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	8609000	USD
	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	5392000	USD
CY2013Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	3244000	USD
CY2012Q3	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2103000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	8772000	USD
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	5721000	USD
CY2013Q3	us-gaap	Operating Expenses OperatingExpenses	11695000	USD
CY2012Q3	us-gaap	Operating Expenses OperatingExpenses	8163000	USD
	us-gaap	Operating Expenses OperatingExpenses	32457000	USD
	us-gaap	Operating Expenses OperatingExpenses	20984000	USD
CY2013Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-6101000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-17411000	USD
	us-gaap	Operating Income Loss OperatingIncomeLoss	-13813000	USD
CY2012Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-4939000	USD
CY2013Q3	us-gaap	Interest Expense InterestExpense	126000	USD
	us-gaap	Interest Expense InterestExpense	131000	USD
CY2013Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-76000	USD
CY2012Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2146000	USD
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	USD
CY2013Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-6303000	USD
CY2012Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4938000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-19688000	USD
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-13812000	USD
CY2013Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-6.59
CY2012Q3	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-7.49
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-22.87
	us-gaap	Earnings Per Share Basic And Diluted EarningsPerShareBasicAndDiluted	-21.40
CY2013Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	955890	shares
CY2012Q3	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	659129	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	860957	shares
	us-gaap	Weighted Average Number Of Share Outstanding Basic And Diluted WeightedAverageNumberOfShareOutstandingBasicAndDiluted	645306	shares
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	526000	USD
	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	1875000	USD
	us-gaap	Recognition Of Deferred Revenue RecognitionOfDeferredRevenue	1761000	USD
	vcyt	Share Based Compensation Non Bonus Related ShareBasedCompensationNonBonusRelated	851000	USD
	vcyt	Share Based Compensation Non Bonus Related ShareBasedCompensationNonBonusRelated	458000	USD
	vcyt	Share Based Compensation Bonus Related ShareBasedCompensationBonusRelated	203000	USD
	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	28000	USD
	us-gaap	Fair Value Liabilities Measured On Recurring Basis Change In Unrealized Gain Loss FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss	-2070000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	329000	USD
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	482000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	342000	USD
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	488000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2183000	USD
	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	287000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	-32000	USD
	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	58000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	3813000	USD
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	747000	USD
	vcyt	Increase Decrease In Accrued Liabilities And Deferred Rent IncreaseDecreaseInAccruedLiabilitiesAndDeferredRent	763000	USD
	vcyt	Increase Decrease In Accrued Liabilities And Deferred Rent IncreaseDecreaseInAccruedLiabilitiesAndDeferredRent	1531000	USD
	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	10000000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-15861000	USD
	us-gaap	Net Cash Provided By Used In Operating Activities Continuing Operations NetCashProvidedByUsedInOperatingActivitiesContinuingOperations	-3279000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1061000	USD
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	912000	USD
	us-gaap	Increase Decrease In Restricted Cash IncreaseDecreaseInRestrictedCash	-50000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-1011000	USD
	us-gaap	Net Cash Provided By Used In Investing Activities Continuing Operations NetCashProvidedByUsedInInvestingActivitiesContinuingOperations	-912000	USD
	us-gaap	Proceeds From Issuance Of Redeemable Convertible Preferred Stock ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock	12945000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	474000	USD
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	66000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	18296000	USD
	us-gaap	Net Cash Provided By Used In Financing Activities Continuing Operations NetCashProvidedByUsedInFinancingActivitiesContinuingOperations	66000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	1424000	USD
	us-gaap	Net Cash Provided By Used In Continuing Operations NetCashProvidedByUsedInContinuingOperations	-4125000	USD
CY2012Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	3441000	USD
	vcyt	Preferred Stock Warrants Issued PreferredStockWarrantsIssued	175000	USD
CY2013Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	5000000	USD
CY2013Q1	vcyt	Income Taxes Period For Which Research Tax Credit Extended For Qualified Research Expenditures Incurred Through End Of Specified Period IncomeTaxesPeriodForWhichResearchTaxCreditExtendedForQualifiedResearchExpendituresIncurredThroughEndOfSpecifiedPeriod	P2Y
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	17377692	shares
	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	13466803	shares
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	item
	us-gaap	Interest Expense Debt InterestExpenseDebt	21000	USD
	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	77000	USD
CY2013Q3	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	700000	USD
CY2013Q3	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	0	USD

Files In Submission

Name	View Source	Status
0001104659-13-086891-index-headers.html	Edgar Link	pending
0001104659-13-086891-index.html	Edgar Link	pending
0001104659-13-086891.txt	Edgar Link	pending
0001104659-13-086891-xbrl.zip	Edgar Link	pending
a13-23613_110q.htm	Edgar Link	pending
a13-23613_1ex31d1.htm	Edgar Link	pending
a13-23613_1ex31d2.htm	Edgar Link	pending
a13-23613_1ex32d1.htm	Edgar Link	pending
a13-23613_1ex32d2.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xls	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
vcyt-20130930.xml	Edgar Link	completed
vcyt-20130930.xsd	Edgar Link	pending
vcyt-20130930_cal.xml	Edgar Link	unprocessable
vcyt-20130930_def.xml	Edgar Link	unprocessable
vcyt-20130930_lab.xml	Edgar Link	unprocessable
vcyt-20130930_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$VCYT
VERACYTE, INC. Stock $vcyt

2013 Q4 Form 10-Q Financial Statement

#000110465913086891 Filed on November 25, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VCYT VERACYTE, INC. Stock $vcyt

2013 Q4 Form 10-Q Financial Statement

#000110465913086891 Filed on November 25, 2013

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$VCYT
VERACYTE, INC. Stock $vcyt